Author

M. I. Molaro

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Diabetes mellitus and 10-year outcomes after percutaneous coronary intervention with drug eluting stents: insights from the DECADE cooperation

Diabetes is a significant predictor of adverse cardiovascular events following percutaneous coronary intervention (PCI). However, comprehensive data on very long-term outcomes in the era of drug-eluting stents (DES) is still limited. To assess the impact of diabetes on clinical outcomes after PCI with DES...

M. I. Molaro, F. Simonetti, T. Lenz et al. · European Heart Journal · 0 citations

Open access Oct 2026

Risk of restenosis for in-stent restenosis and de novo lesions treated during the same percutaneous coronary intervention procedure

Patients undergoing percutaneous coronary intervention (PCI) for in-stent restenosis (ISR) lesions have been reported to experience worse outcomes than those treated for de novo lesions. However, no study has yet directly compared these two lesion types when treated in the same patient during the same procedure....

D. Lahu, S. Lahu, F. Simonetti et al. · European Heart Journal · 0 citations

Review Open access Sep 2026

Percutaneous left atrial appendage occlusion versus oral anticoagulation in patients with atrial fibrillation: a systematic review and meta-analysis.

INTRODUCTION AND OBJECTIVES Percutaneous left atrial appendage occlusion (LAAO) has emerged as an alternative to oral anticoagulants (OACs) in patients with atrial fibrillation (AF). However, up-to-date comparisons are lacking. We performed a systematic review and meta-analysis of randomized clinical trials comparing p...

M. I. Molaro, Cajetan Reichardt, F. Simonetti et al. · Revista Española de Cardiolo... · 0 citations